Cytosorbents Corporation (CTSO) Financial Statements (2024 and earlier)

Company Profile

Business Address 305 COLLEGE ROAD EAST
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments22,14552,13871,42212,23222,36917,322
Cash and cash equivalents22,14552,13871,42212,23222,36917,322
Receivables5,6654,5235,1594,4673,9432,206
Inventory, net of allowances, customer advances and progress billings3,4624,7662,6742,114833796
Inventory3,4624,7662,6742,114833796
Contract with customer, asset, after allowance for credit loss   2,997  
Other undisclosed current assets2,4892,8722022,0881,119416
Total current assets:33,76064,29982,45320,90228,26420,739
Noncurrent Assets
Operating lease, right-of-use asset12,60413,4231,0291,071
Property, plant and equipment10,7435,1512,1201,9251,7301,403
Restricted cash and investments1,6871,687    
Other noncurrent assets4,4374,9594,3483,4852,7531,961
Total noncurrent assets:29,47225,2207,4976,4814,4833,364
TOTAL ASSETS:63,23289,51989,95027,38332,74724,103
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,5064,0032,4672,7772,0421,645
Interest and dividends payable  1097779
Employee-related liabilities154    
Accounts payable1,6552,8051,8352,0391,4861,244
Accrued liabilities 8511,044632629480322
Deferred revenue 1,5171,947728172
Debt   2,0956674,000
Customer advances and deposits15
Contract with customer, liability42
Other undisclosed current liabilities5,6927,7396,9584,8933,7872,188
Total current liabilities:9,71513,69010,1539,9366,5387,848
Noncurrent Liabilities
Long-term debt and lease obligation5,00013,25158214,0289,2755,992
Long-term debt, excluding current maturities5,000  13,3869,2755,992
Liabilities, other than long-term debt13,142     
Operating lease, liability13,14213,251582643
Other undisclosed noncurrent liabilities  (13,251)(582)   
Total noncurrent liabilities:18,14213,25158214,0289,2755,992
Total liabilities:27,85726,94110,73523,96415,81313,840
Equity
Equity, attributable to parent35,37562,57879,2163,41816,93510,263
Common stock444343333229
Additional paid in capital287,000283,194277,533191,649186,138162,907
Accumulated other comprehensive income (loss)2,329526(1,734)526288(361)
Accumulated deficit(253,998)(221,185)(196,627)(188,789)(169,524)(152,313)
Total equity:35,37562,57879,2163,41816,93510,263
TOTAL LIABILITIES AND EQUITY:63,23289,51989,95027,38332,74724,103

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues34,68943,16641,00524,94922,50415,151
Revenue, net15,151
Cost of revenue
(Cost of Goods and Services Sold)
(13,956)(11,047)(11,052)(7,364)(7,489)(5,518)
Gross profit:20,73332,11829,95217,58615,0159,632
Operating expenses(52,255)(54,863)(40,323)(36,560)(30,599)(19,475)
Operating loss:(31,522)(22,745)(10,370)(18,974)(15,585)(9,843)
Nonoperating income (expense)(2,383)(2,550)1,406(1,384)(2,246)705
Gain (loss), foreign currency transaction, before tax(2,449)(2,578)2,607(350)(785)1,454
Loss from continuing operations before income taxes:(33,905)(25,295)(8,964)(20,358)(17,831)(9,138)
Income tax benefit 1,0937361,1271,092620677
Other undisclosed income from continuing operations      
Loss from continuing operations:(32,813)(24,559)(7,837)(19,266)(17,211)(8,461)
Loss before gain (loss) on sale of properties:(24,559)(7,837)(19,266)(17,211)(8,461)
Net loss attributable to parent:(32,813)(24,559)(7,837)(19,266)(17,211)(8,461)
Preferred stock dividends and other adjustments      (336)
Net loss available to common stockholders, diluted:(32,813)(24,559)(7,837)(19,266)(17,211)(8,797)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(32,813)(24,559)(7,837)(19,266)(17,211)(8,461)
Comprehensive loss:(32,813)(24,559)(7,837)(19,266)(17,211)(8,461)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,8042,260(2,260)238649(1,260)
Comprehensive loss, net of tax, attributable to parent:(31,009)(22,299)(10,097)(19,028)(16,562)(9,720)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: